![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Convatec Group Plc | LSE:CTEC | London | Ordinary Share | GB00BD3VFW73 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.20 | -0.49% | 243.20 | 243.00 | 243.40 | 245.20 | 242.20 | 244.80 | 10,007,813 | 16:35:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 2.14B | 130.3M | 0.0636 | 38.21 | 5.01B |
Convatec Group PLC (CTEC) Convatec Group PLC: Scrip Dividend - Calculation Price 25-Aug-2023 / 19:12 GMT/BST =---------------------------------------------------------------------------------------------------------------------- 25 August 2023 Convatec Group Plc ("Convatec" or "the Company") Scrip Dividend - Calculation Price On 2 August 2023, the Board of Directors of Convatec Group Plc ("Convatec" or "the Company") declared an interim dividend of 1.769 cents per share ("Interim Dividend"). This Interim Dividend is to be paid on 28 September 2023 to shareholders on the share register as of 18 August 2023 ("Record Date"). The Interim Dividend is payable in cash, in sterling to holders of ordinary shares. The chosen exchange rate for this payment is USUSD1.282 /GBP1.00, determined on 1 August 2023, giving a total sterling dividend of GBP28,226,583. A scrip dividend will be made available for this Interim Dividend, allowing shareholders to elect to receive their dividend in the form of new ordinary shares. The "Calculation Price" for the issue of new ordinary shares under the scrip dividend scheme is: 221.0 pence for each new ordinary share. This is equivalent to 1 new share for approximately 160.14 shares held prior to the ex-dividend date of 17 August 2023. The Calculation Price is the average of the middle market quotations of a Convatec share, derived from the London Stock Exchange Daily Official List, for the five consecutive business days from 17 August to 23 August 2023 (inclusive). The latest date for receipt of elections to participate in the scrip dividend scheme for the Interim Dividend is 7 September 2023. Shareholders must return their mandate form by 5pm (BST) or otherwise input their CREST elections to be received by the Company's registrar, Computershare, by 3pm (BST) on 7 September 2023. Elections received after this deadline will apply to subsequent dividends only. Unless revoked by you, your scrip dividend election will apply for all future dividends for which a scrip dividend is offered. Evergreen elections for CREST shareholders cannot be accepted and elections will revert to cash by default after the payment of each dividend. Details of the scrip dividend scheme are available at https://www.convatecgroup.com/investors/shareholder-centre/ dividend-information/ TIMETABLE Key dates in respect of the scrip dividend scheme for the Interim Dividend are: Ex-dividend Date 17 August 2023 Record Date 18 August 2023 Scrip calculation price determined 17-23 August 2023 (inclusive) Mandate delivery deadline for Shares held in uncertificated form 3.00 p.m. on 7 September 2023 Mandate delivery deadline for Shares held in certificated form 5.00 p.m. on 7 September 2023 Announcement of the total amount of new shares to be issued 15 September 2023 Dividend payment date 28 September 2023 Dispatch of statement in accordance with section 7 of Scheme 28 September 2023
Enquiries
Kate Postans, VP Investor Relations +44 (0)782 644 7807
ir@convatec.com
Convatec Group Plc's LEI code is 213800LS272L4FIDOH92
About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence care and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2022 were over USD2 billion. The company is a constituent of the FTSE 100 Index (LSE: CTEC). To learn more about Convatec, please visit www.convatecgroup.com.
----------------------------------------------------------------------------------------------------------------------- Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
-----------------------------------------------------------------------------------------------------------------------
ISIN: GB00BD3VFW73 Category Code: DIV TIDM: CTEC LEI Code: 213800LS272L4FIDOH92 Sequence No.: 267296 EQS News ID: 1712219 End of Announcement EQS News Service =------------------------------------------------------------------------------------
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1712219&application_name=news
(END) Dow Jones Newswires
August 25, 2023 14:13 ET (18:13 GMT)
1 Year Convatec Chart |
1 Month Convatec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions